{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-110191","form_type":"8-K","ticker":"ADIL","cik":"0001513525","company_name":"ADIAL PHARMACEUTICALS, INC.","filed_at":"2024-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.648049+00:00","generated_at":"2026-05-29T01:58:49.116013+00:00","sec_items":["1.01","1.02","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Adial enters $5M equity purchase agreement with Alumni Capital, terminates prior deal","bullets":["Company can sell up to $5M (option to $10M) of common stock to Alumni Capital at 97% of VWAP, with $0.55/share floor.","Issued 68,807 commitment shares as consideration; prior May 2023 agreement terminated.","Sales at Company's discretion; proceeds for strategic opportunities, working capital, general corporate purposes.","Agreement runs through Dec 31, 2026; Company can terminate on 10 days' notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-110191","json":"https://secwatch.observer/filing/0001213900-24-110191.json","markdown":"https://secwatch.observer/filing/0001213900-24-110191.md","text":"https://secwatch.observer/filing/0001213900-24-110191.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1513525/000121390024110191/0001213900-24-110191-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1513525/000121390024110191/ea0225021-8k_adialpharm.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T01:58:49.116013+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}